References
- Christiansen M, Ishiguro T, Høgdall C, Nørgaard-Pedersen B. Alpha-fetoprotein. Updating on tumor markers in tissue and in biological fluids: Basic aspects and clinical applications, A Ballesta, et al. Edizione Minerva Medica, Torino 1993; 245–69
- Taketa K. Alpha-fetoprotein: Reevaluation in hepatology. Hepatology 1990; 12: 1420–32
- Lehmann F G. Early detection of hepatoma: prospective study in liver cirrhosis using passive hemagglutination and the radioimmunoassay. Ann N Y Acad Sci 1975; 259: 196–210
- Mendenhall C L, Chedid A, French S W, et al. Alpha-fetoprotein alterations in alcoholics with liver disease. Alcohol Alcohol 1991; 26: 527–34
- Nayak S S, Kamath S S, Kundaje G N, Aroor A R. Diagnostic significance of estimation of serum apolipoprotein A along with alpha-fetoprotein in alcoholic cirrhosis and hepatocellular carcinoma. Clin Chim Acta 1988; 173: 157–64
- Bell H. Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease. Scand J Gastroenterol 1982; 17: 897–903
- Stibler H, Borg S, Joustra M. Micro anion exchange chromatography of “carbohydrate-deficient transferrin” (CDT) in serum in relation to alcohol consumption. Alcohol Clin Exp Res 1986; 10: 535–44
- Holt S, Skinner H A, Israel Y. Early identification of alcohol abuse: 2: Clinical and laboratory indicators. Can Med Assoc J 1981; 124: 1279–99
- Selzer M L. The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. Am J Psychiatr 1971; 127: 1653–8
- Ball D, Rose E, Alpert E. Alpha-fetoprotein levels in normal adults. Am J Med Sci, 303: 157–9
- Christoffersen P, Nielsen K. Histological changes in human liver biopsies from chronic alcoholics. Acta Path Microbiol Scand Section A 1972; 80: 557–65
- Stibler H, Hultcrantz R. Carbohydrate-deficient transferrin in serum in patients with liver diseases. Alcohol Clin Exp Res 1987; 11: 468–73
- Gleiberman A, Abelev G I. Cell position and cell interactions in expression of fetal phenotype of hepatocyte. Int Rev Cytol 1985; 95: 229–66
- Sakamoto S I, Yachi A, Anzai T, Wada T. AFP-producing cells in hepatitis and liver cirrhosis. Ann N Y Acad Sci 1975; 259: 253–8
- Bloomer J R, Waldmann T A, McLntire K R, Klatskin G. Serum alpha-fetoprotein in patients with massive hepatic necrosis. Gastroenterology 1977; 72: 479–82
- Sell S. Is there a liver stem cell?. Cancer Res 1990; 50: 3811–15
- Nørgaard-Pedersen B, Christiansen M, Jensen S P. Alpha-fetoprotein in fetal pathology. Hormones and fetal pathophysiology, J R Pasqua-Lini, R Scholler. Marcel Dekker, New York 1992; 369–412
- Nørgaard-Pedersen B, Schultz H, Arends J, et al. Tumour markers in testicular germ cell tumours. Five-year experience from the Dateca study 1976–1980. Acta Radiol Oncol 1984; 23: 287–93
- Kaczynski J, Jagenburg R, Lindstedt G, Waller-Stedt S. Markedly increased alpha-fetoprotein concentration in serum in alcoholic liver disease: Malignant tumor or nonneoplastic changes?. Clin Chem 1992; 38: 710–6
- Hida S, Nishimura K, Nishio Y, Oishi K, Takeuchi H, Yoshida O. VAB-6 chemotherapy causes spurious elevation of alpha-fetoprotein associated with liver dysfunctions. Urol Int 1991; 46: 1–5